Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters-Reference-Cited by-同舟云学术

Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters

Published:2009-12 Issue:10 Volume:41 Page:4181-4183
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Seymen P.,Yildiz M.,Türkmen M.F.,Titiz M.İ.,Seymen H.O.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference17 articles.

1. Hyperlipidemia in renal transplant recipients;Donald;Graft,2000

2. Lipid abnormalities in cyclosporin-prednisone-treated renal transplant recipients;Vathsala;Transplantation,1989

3. Relationship of cyclosporin and sirolimus blood concentrations regarding the incidence and severity of hyperlipidemia after kidney transplantation;Spinelli;Braz J Med Biol Res,2006

4. Persistent hyperlipidemia in renal transplant recipients;Kasiske;Medicine,1987

5. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients;Baid Aqraval;Transplantation,2004

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extrahepatic causes of morbidity and mortality of liver recipients in the long-term posttransplantation period;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2023-09-14

2. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

3. Calcineurin inhibitors’ impact on cardiovascular and renal function, a descriptive study in lung transplant recipients from the North of Spain;Scientific Reports;2022-12-08

4. Dyslipidemia in Chronic Kidney Disease;Evidence‐Based Nephrology;2022-11-18

5. Lipid management to mitigate poorer postkidney transplant outcomes;Current Opinion in Nephrology & Hypertension;2022-10-11